OniLon: Phase II trial of trifluridine/tipiracil (TAS-102) and nanoliposomal irinotecan (nal-IRI) in advanced colorectal cancer. Efficacy and safety of fruquintinib plus investigator's choice of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results